- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02370290
Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
CT Metrology: Quantitative Imaging Metrics With Advanced Visualization Tools for Cancer Imaging
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. To investigate the role of quantitative imaging metrics (QIM) as a potential DIAGNOSTIC biomarker.
II. To investigate if QIM parameters can differentiate clear cell renal cell carcinoma (RCC) from papillary RCC.
III. To evaluate the tumor grade of the target lesion as assessed by QIM from CECT for agreement with the pathological (Fuhrman) grade.
IV. To investigate the role of QIM as a potential PROGNOSTIC biomarker. V. To develop a novel method of calculating renal tumor contact surface area (CSA) using advanced image-processing technology (MATLAB®, 3 dimension [D] Synapse) and predict peri-operative variables such as blood loss, operative time and post-operative estimated glomerular filtration rate (eGFR) in patients undergoing partial nephrectomy (PN).
VI. To develop QIM that would help in predicting postoperative functional outcomes such as predicted surgically resected volume and postoperative glomerular filtration rate (GFR).
OUTLINE:
Patients' clinical and imaging data are collected from routine multiphase CECT imaging and used to establish and validate the classification/prediction rule for QIM.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
California
-
Los Angeles, California, Forente stater, 90033
- USC Norris Comprehensive Cancer Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Subjects with a renal mass who are scheduled for surgery for presumed RCC
- Subjects scheduled for standard of care contrast enhanced CT examination at USC Norris Comprehensive Cancer Center
- Subjects competent to sign study specific written informed consent
Exclusion Criteria:
- Subjects who are pregnant
- Subjects who cannot consent for themselves
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Observational (QIM)
Patients' clinical and imaging data are collected from routine multiphase CECT imaging and used to establish and validate the classification/prediction rule for QIM.
|
Clinical and imaging information collected
Andre navn:
Clinical and imaging data collected
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Agreement between QIM predicted and pathologically determined tumor class (clear cell renal cell carcinoma [ccRCC] vs papillary [p]RCC)
Tidsramme: Baseline
|
Cohen's kappa coefficient will be used to examine the agreement between QIM predicted and pathologically determined tumor class (ccRCC vs. pRCC).
|
Baseline
|
Agreement between QIM predicted and pathologically determined tumor (Fuhrman) grade
Tidsramme: Baseline
|
Examined using weighted kappa coefficient.
|
Baseline
|
Agreement between QIM predicted and clinically observed perioperative measurements such as blood loss, operative time, and eGFR
Tidsramme: Baseline
|
Examined using two-way random single measure with absolute agreement.
|
Baseline
|
Agreement between QIM predicted and clinical determined postoperative eGFR
Tidsramme: Baseline
|
Examined using two-way random single measure with absolute agreement.
|
Baseline
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Vinay Duddalwar, University of Southern California
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 4K-13-2 (Annen identifikator: USC Norris Comprehensive Cancer Center)
- P30CA014089 (U.S. NIH-stipend/kontrakt)
- NCI-2014-02547 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
- HS-13-00256
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Nyrecellekarsinom
-
Debiopharm International SARekrutteringPankreas duktal adenokarsinom (PDAC) | Kolorektal kreft (CRC) | Clear Cell Renal Cell Cancer (ccRCC)Frankrike, Australia
-
University of Michigan Rogel Cancer CenterFullførtNyrecellekarsinomForente stater
-
Universitaire Ziekenhuizen KU LeuvenFullførtForekomst av utvidet renal clearance | Risikofaktorer for økt renal clearanceBelgia
-
Second Affiliated Hospital of Guangzhou Medical...Hunan Zhaotai Yongren Medical Innovation Co. Ltd.RekrutteringAnti-kreft celle immunterapi | T Cell og NK CellKina
-
Andrew B AdamsBristol-Myers SquibbFullført
-
University Health Network, TorontoFullførtGlomerulær filtreringshastighet | Renal blodstrømCanada
-
Oregon Health and Science UniversityFullført
-
Peking University People's HospitalUkjentNatural Killer Cell Medited ImmunitetKina
-
Center for International Blood and Marrow Transplant...Cellular Dynamics International, Inc. - A FUJIFILM CompanyAvsluttetiPS Cell Manufacturing and Banking
-
Erling Bjerregaard PedersenUniversity of AarhusUkjentRenal rørtransportDanmark
Kliniske studier på Medical Chart Review
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Avsluttet
-
M.D. Anderson Cancer CenterRekrutteringHematopoetisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForente stater
-
Mayo ClinicNational Cancer Institute (NCI)FullførtOndartet neoplasma i sentralnervesystemet | Ondartet skull base neoplasmaForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RekrutteringHematopoetisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForente stater
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company...FullførtForekomst og forekomst av kreft hos mennesker som lever med HIV/AIDS ved kreftsentre i Latin-AmerikaHIV-infeksjon | Ondartet neoplasma | Tilbakevendende ondartet neoplasma | Humant immunsviktvirus 1 positivMexico, Argentina, Brasil
-
M.D. Anderson Cancer CenterRekrutteringKutant melanomForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeHode- og nakkekarsinomForente stater
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)FullførtTilbakevendende uterin Corpus Sarkom | Tilbakevendende livmorkarsinom | Stadium I Livmor Corpus Cancer | Stadium II Livmor Corpus Cancer | Stadium III Livmor Corpus Cancer | Stadium IV Livmor Corpus Cancer | Tilbakevendende livmorhalskreft | Stadium III livmorsarkom | Stadium IV livmorsarkom | Stadium I livmorsarkom og andre forholdForente stater
-
M.D. Anderson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)RekrutteringBronchiolitis ObliteransForente stater
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of California, San Diego; University...AvsluttetAIDS-relatert primært effusjonslymfomForente stater